cyclosporine has been researched along with Peritoneal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hilal, G; Kattan, J; Khazzaka, A; Rassy, E; Sarkis, R; Track-Smayra, V | 1 |
| Baba, E; Katano, M; Matsunaga, H; Morisaki, T; Nakahara, C; Nakamura, K; Noshiro, H; Tanaka, M; Wada, M; Yamanaka, N | 1 |
| Ellis, T; Jamieson, GG; Neuhaus, SJ; Rofe, AM; Watson, DI | 1 |
3 other study(ies) available for cyclosporine and Peritoneal Neoplasms
| Article | Year |
|---|---|
Peritoneal Carcinomatosis of Colorectal Origin in Cyclosporine Immunosuppressed Rats.
Topics: Animals; Carcinoma; Cyclosporine; Disease Models, Animal; Humans; Male; Peritoneal Neoplasms; Rats; Rats, Sprague-Dawley | 2020 |
Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase Inhibitors; Caspases; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cyclosporine; Docetaxel; Drug Combinations; Enzyme Inhibitors; Female; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Peritoneal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured | 2003 |
The effect of immune enhancement and suppression on the development of laparoscopic port site metastases.
Topics: Abdominal Muscles; Adjuvants, Immunologic; Animals; Cyclosporine; Disease Models, Animal; Endotoxins; Immunosuppressive Agents; Laparoscopy; Male; Neoplasm Metastasis; Neoplasm Seeding; Peritoneal Neoplasms; Rats; Rats, Inbred Strains | 2000 |